Search

Your search keyword '"progression"' showing total 48 results

Search Constraints

Start Over You searched for: Descriptor "progression" Remove constraint Descriptor: "progression" Journal cancer cell international Remove constraint Journal: cancer cell international
48 results on '"progression"'

Search Results

1. The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma

2. The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma.

3. Identification of a RAD51B enhancer variant for susceptibility and progression to glioma

4. Identification of a RAD51B enhancer variant for susceptibility and progression to glioma.

5. Emerging roles for lncRNA-NEAT1 in colorectal cancer

6. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway

7. LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes

8. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT

9. miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway

10. Emerging roles for lncRNA-NEAT1 in colorectal cancer.

11. Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors

12. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis

13. CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p

14. LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes.

15. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway.

16. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT.

17. miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway.

18. Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition

19. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer

20. SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis

21. Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p

22. TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer

23. Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors.

24. miR-190-5p in human diseases

25. Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression

26. Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas

27. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression

28. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis.

29. CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p.

30. Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression

31. Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition.

32. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer.

33. SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis.

34. TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer.

35. Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition

36. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway

37. Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors

38. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer

42. miR-190-5p in human diseases

43. TGF-β1 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer

44. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression

45. Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression

46. miR-190-5p in human diseases.

47. Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas.

48. Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.

Catalog

Books, media, physical & digital resources